Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Non-small Lung Cancer × toripalimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Cancer 1 Skin Neoplasms 1 Non-small Lung Cancer 1 Neuroendocrine Tumors 1 Neoplasms 1 Meningeal Carcinomatosis 1 Local Advanced Non-small Cell Lung Cancer 1 Klatskin Tumor 1 Gallbladder Neoplasms 1 DMMR Colorectal Cancer 1 Carcinoma, Renal Cell 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06293690 2025-12-18

Toripalimab Combined With SBRT for NSCLC

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Active not recruiting

Non-small Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡